logo

For the Inventor, By the Inventor

Groton, CT, United States of America

Leland D Loose

This inventor holds 4 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 1991-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leland D Loose. Retrieved from https://idiyas.com/inventor/leland-d-loose

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 1.7

ph-index = 3

Forward Citations = 44(Granted Patents)


Location History:

  • Groton, CT (US) (1991)
  • Norwich, CT (US) (1992 - 1996)

Company Filing History:

goldMedal4 out of 4,489 
 
Pfizer Corporation
 patents

Years Active: 1991-1996

Loading Chart...
4 patents (USPTO):Explore Patents
1. 5545656 - 2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of (1996-08-13),
2. 5122534 - Use of tenidap to reduce total serum cholesterol, LDL cholesterol and (1992-06-16),
3. 5008283 - Use of tenidap to inhibit activation of collagenase and to inhibit the (1991-04-16),
4. 5006547 - Tenidap as an inhibitor of the release of elastase by neutrophils (1991-04-09),

Title: Leland D Loose: Innovator in Pharmaceutical Agents

Introduction

Leland D Loose is a notable inventor based in Groton, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of agents aimed at treating various health conditions. With a total of 4 patents to his name, his work has had a meaningful impact on medical science.

Latest Patents

Among his latest patents, Leland has developed a pharmaceutical agent known as 2-Oxidole-1-carboxamide. This invention focuses on the use of certain 3-substituted 2-oxindole-1-carboxamides and their pharmaceutically acceptable base salts for the treatment or prevention of Alzheimer's disease in mammals, including humans. Another significant patent involves the use of tenidap, which is shown as the enolic form of 5-chloro-2,3-dihydro-2-oxo-3-(2-thienylcarbonyl)-indole-1-carboxamide. This invention aims to reduce total serum cholesterol, LDL cholesterol, and triglycerides in mammals suffering from inflammatory arthritic conditions.

Career Highlights

Leland D Loose has established a successful career at Pfizer Corporation, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving health outcomes through scientific research and development.

Collaborations

Throughout his career, Leland has collaborated with esteemed colleagues such as Joseph G Lombardino and Ethan S Weiner. These partnerships have further enhanced the quality and impact of his inventions.

Conclusion

Leland D Loose stands out as a prominent inventor in the pharmaceutical industry, with a focus on developing innovative treatments for serious health conditions. His contributions continue to shape the future of medicine and improve the lives of many.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…